Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Grossbard

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Lymphoma|April 10, 2004
Alemtuzumab in B-cell chronic lymphocytic leukemiaIlan Shapira, Michael L Grossbard
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2004
Empowering targeted therapy: lessons from rituximabAdam J Olszewski, Michael L Grossbard
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Hepatosplenic γδ T-cell lymphoma: an overviewKoppany Visnyei, Michael L Grossbard, Ilan Shapira
Clinical Breast Cancer|August 12, 2011
Breast cancer in female-to-male transsexuals: two cases with a review of physiology and managementTheresa Shao, Michael L Grossbard, Paula Klein
The Oncologist|June 3, 2008
Metastatic pancreatic cancer 2008: is the glass less empty?Jacqueline Nieto, Michael L Grossbard, Peter Kozuch
The Oncologist|January 12, 2012
Vitamin D and breast cancerTheresa Shao, Paula Klein, Michael L Grossbard
American Journal of Hematology|December 4, 2008
Optimal response to 100 microg/kg anti-Rh(D) in two patients who had suboptimal responses to 75 microg/kg anti-Rh(D)Mala Varma, Elizabeth J Beautyman, Michael L Grossbard
Oncology (Williston Park, N.Y.)|April 15, 2005
The horizon of antiangiogenic therapy for colorectal cancerAdam J Olszewski, Michael L Grossbard, Peter S Kozuch
Clinical Lymphoma & Myeloma|June 16, 2009
Primary central nervous system mucosa-associated lymphoid tissue lymphoma: case report and literature reviewWajeeha Razaq, Anupama Goel, Ali Amin, et al.
The Oncologist|February 27, 2003
Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative careFrancois G el-Kamar, Michael L Grossbard, Peter S Kozuch
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma|April 10, 2004
Alemtuzumab in B-cell chronic lymphocytic leukemiaIlan Shapira, Michael L Grossbard
Science'S STKE : Signal Transduction Knowledge Environment|July 15, 2004
Empowering targeted therapy: lessons from rituximabAdam J Olszewski, Michael L Grossbard
Clinical Lymphoma, Myeloma & Leukemia|July 24, 2013
Hepatosplenic γδ T-cell lymphoma: an overviewKoppany Visnyei, Michael L Grossbard, Ilan Shapira
Clinical Breast Cancer|August 12, 2011
Breast cancer in female-to-male transsexuals: two cases with a review of physiology and managementTheresa Shao, Michael L Grossbard, Paula Klein
The Oncologist|June 3, 2008
Metastatic pancreatic cancer 2008: is the glass less empty?Jacqueline Nieto, Michael L Grossbard, Peter Kozuch
The Oncologist|January 12, 2012
Vitamin D and breast cancerTheresa Shao, Paula Klein, Michael L Grossbard
American Journal of Hematology|December 4, 2008
Optimal response to 100 microg/kg anti-Rh(D) in two patients who had suboptimal responses to 75 microg/kg anti-Rh(D)Mala Varma, Elizabeth J Beautyman, Michael L Grossbard
Oncology (Williston Park, N.Y.)|April 15, 2005
The horizon of antiangiogenic therapy for colorectal cancerAdam J Olszewski, Michael L Grossbard, Peter S Kozuch
Clinical Lymphoma & Myeloma|June 16, 2009
Primary central nervous system mucosa-associated lymphoid tissue lymphoma: case report and literature reviewWajeeha Razaq, Anupama Goel, Ali Amin, et al.
The Oncologist|February 27, 2003
Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative careFrancois G el-Kamar, Michael L Grossbard, Peter S Kozuch
Pageof 4